'Staggering' Weight Loss With Tirzepatide

Over 60% of participants achieved the weight-reduction target of 20% or higher and had improved body composition in a phase 3 trial of tirzepatide in overweight/obesity.

Related Keywords

New York ,United States ,Israel ,Dublin ,Ireland ,Israeli ,Louis Aronne ,Gabriella Lieberman ,Eli Lilly ,Drug Administration ,European Congress On Obesity ,Weight Control Center ,Israeli Center ,Sheba Medical Center ,European Medicines Agency ,Comprehensive Weight Control Center ,Weill Cornell Medicine ,New England Journal ,Weight Management ,Medscape Medical ,Body Composition ,Obesity ,Bese ,Bariatric Surgery ,Obesity Surgery ,Weight Loss Surgery ,Urgery Weight Loss ,Weight Loss ,Body Mass Index Bmi ,Incretin Hormones ,Incretins ,Glp 1 Receptor Agonists ,Glucagon Like Peptide 1 Receptor Agonists ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,